NEW YORK (360Dx) – Siemens Healthineers said today that the US Food and Drug Administration has granted Breakthrough Device designation for its Advia Centaur Enhanced Liver Fibrosis (ELF) test.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.